217 related articles for article (PubMed ID: 36890041)
21. [Research progress of long-chain non-coding RNA in lipid metabolism reprogramming in primary hepatocellular carcinoma].
Yu Z; Chen DM; Huang JL
Zhonghua Gan Zang Bing Za Zhi; 2024 Feb; 32(2):180-185. PubMed ID: 38514271
[TBL] [Abstract][Full Text] [Related]
22. Yin Yang 1 facilitates hepatocellular carcinoma cell lipid metabolism and tumor progression by inhibiting PGC-1β-induced fatty acid oxidation.
Li Y; Kasim V; Yan X; Li L; Meliala ITS; Huang C; Li Z; Lei K; Song G; Zheng X; Wu S
Theranostics; 2019; 9(25):7599-7615. PubMed ID: 31695789
[TBL] [Abstract][Full Text] [Related]
23. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA.
Panzitt K; Tschernatsch MM; Guelly C; Moustafa T; Stradner M; Strohmaier HM; Buck CR; Denk H; Schroeder R; Trauner M; Zatloukal K
Gastroenterology; 2007 Jan; 132(1):330-42. PubMed ID: 17241883
[TBL] [Abstract][Full Text] [Related]
24. Identification and validation of a fatty acid metabolism-related lncRNA signature as a predictor for prognosis and immunotherapy in patients with liver cancer.
Chen E; Yi J; Jiang J; Zou Z; Mo Y; Ren Q; Lin Z; Lu Y; Zhang J; Liu J
BMC Cancer; 2022 Oct; 22(1):1037. PubMed ID: 36195833
[TBL] [Abstract][Full Text] [Related]
25. Emerging roles and potential clinical applications of noncoding RNAs in hepatocellular carcinoma.
Cao P; Jin Q; Feng L; Li H; Qin G; Zhou G
Semin Cancer Biol; 2021 Oct; 75():136-152. PubMed ID: 32931952
[TBL] [Abstract][Full Text] [Related]
26. A novel lncRNA RP11-386G11.10 reprograms lipid metabolism to promote hepatocellular carcinoma progression.
Xu K; Xia P; Gongye X; Zhang X; Ma S; Chen Z; Zhang H; Liu J; Liu Y; Guo Y; Yao Y; Gao M; Chen Y; Zhang Z; Yuan Y
Mol Metab; 2022 Sep; 63():101540. PubMed ID: 35798238
[TBL] [Abstract][Full Text] [Related]
27. β-catenin-activated hepatocellular carcinomas are addicted to fatty acids.
Senni N; Savall M; Cabrerizo Granados D; Alves-Guerra MC; Sartor C; Lagoutte I; Gougelet A; Terris B; Gilgenkrantz H; Perret C; Colnot S; Bossard P
Gut; 2019 Feb; 68(2):322-334. PubMed ID: 29650531
[TBL] [Abstract][Full Text] [Related]
28. Increased mitochondrial fission drives the reprogramming of fatty acid metabolism in hepatocellular carcinoma cells through suppression of Sirtuin 1.
Wu D; Yang Y; Hou Y; Zhao Z; Liang N; Yuan P; Yang T; Xing J; Li J
Cancer Commun (Lond); 2022 Jan; 42(1):37-55. PubMed ID: 34981667
[TBL] [Abstract][Full Text] [Related]
29. Exploring the Regulatory Role of ncRNA in NAFLD: A Particular Focus on PPARs.
Mukherjee AG; Wanjari UR; Gopalakrishnan AV; Katturajan R; Kannampuzha S; Murali R; Namachivayam A; Ganesan R; Renu K; Dey A; Vellingiri B; Prince SE
Cells; 2022 Dec; 11(24):. PubMed ID: 36552725
[TBL] [Abstract][Full Text] [Related]
30. Non-coding RNAs derailed: The many influences on the fatty acid reprogramming of cancer.
Yu XH; Wang HF; Wu JB; Wang SS; Tang YJ; Tang YL; Liang XH
Life Sci; 2019 Aug; 231():116509. PubMed ID: 31152812
[TBL] [Abstract][Full Text] [Related]
31. Crosstalk between m6A modification and non-coding RNAs in HCC.
Qiu Z; Yuan X; Wang X; Liu S
Cell Signal; 2024 May; 117():111076. PubMed ID: 38309550
[TBL] [Abstract][Full Text] [Related]
32. Hepatocellular carcinoma associated lipid metabolism reprogramming.
Skill NJ; Scott RE; Wu J; Maluccio MA
J Surg Res; 2011 Jul; 169(1):51-6. PubMed ID: 19932908
[TBL] [Abstract][Full Text] [Related]
33. Emerging roles of non-coding RNAs in the metabolic reprogramming of tumor-associated macrophages.
Li J; Lu Z; Zhang Y; Xia L; Su Z
Immunol Lett; 2021 Apr; 232():27-34. PubMed ID: 33577913
[TBL] [Abstract][Full Text] [Related]
34. Long noncoding RNAs: Novel insights into hepatocelluar carcinoma.
He Y; Meng XM; Huang C; Wu BM; Zhang L; Lv XW; Li J
Cancer Lett; 2014 Mar; 344(1):20-27. PubMed ID: 24183851
[TBL] [Abstract][Full Text] [Related]
35. Role and mechanisms of noncoding RNAs in the regulation of metabolic reprogramming in bladder cancer (Review).
Zhang B; Yang L; He Y; Han D; Qi P; Shang P
Int J Mol Med; 2023 Sep; 52(3):. PubMed ID: 37477143
[TBL] [Abstract][Full Text] [Related]
36. HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1α.
Yang N; Wang T; Li Q; Han F; Wang Z; Zhu R; Zhou J
J Cell Physiol; 2021 May; 236(5):3863-3880. PubMed ID: 33305825
[TBL] [Abstract][Full Text] [Related]
37. Suppression of ACADM-Mediated Fatty Acid Oxidation Promotes Hepatocellular Carcinoma via Aberrant CAV1/SREBP1 Signaling.
Ma APY; Yeung CLS; Tey SK; Mao X; Wong SWK; Ng TH; Ko FCF; Kwong EML; Tang AHN; Ng IO; Cai SH; Yun JP; Yam JWP
Cancer Res; 2021 Jul; 81(13):3679-3692. PubMed ID: 33975883
[TBL] [Abstract][Full Text] [Related]
38. Biology and Clinical Application of Regulatory RNAs in Hepatocellular Carcinoma.
Pea A; Jamieson NB; Braconi C
Hepatology; 2021 Jan; 73 Suppl 1():38-48. PubMed ID: 32160335
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis B virus X protein-mediated non-coding RNA aberrations in the development of human hepatocellular carcinoma.
Zhang B; Han S; Feng B; Chu X; Chen L; Wang R
Exp Mol Med; 2017 Feb; 49(2):e293. PubMed ID: 28186085
[TBL] [Abstract][Full Text] [Related]
40. PIWIL1 governs the crosstalk of cancer cell metabolism and immunosuppressive microenvironment in hepatocellular carcinoma.
Wang N; Tan HY; Lu Y; Chan YT; Wang D; Guo W; Xu Y; Zhang C; Chen F; Tang G; Feng Y
Signal Transduct Target Ther; 2021 Feb; 6(1):86. PubMed ID: 33633112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]